Código QR (código de barras bidimensional)

Eribulin plus Pyrotinib in Trastuzumab-Resistant, HER2-Positive Advanced Breast Cancer: A Single-Arm, Multicenter Phase II Trial (EPIC Trial)

Ruoyang Li,1 Meiqi Wang,1 Xiangshun Kong,2 Jie Ma,3 Xiuheng Qi,4 Zhenchuan Song1 1Breast Center, Fourth Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of China; 2Department of Breast Surgery, Xingtai People’s Hospital, Xingtai, People’s Republic of China; 3Department of Breast...

Fuld beskrivelse

Na minha lista:
Principais autores: Li R, Wang M, Kong X, Ma J, Qi X, Song Z
Format: Artigo
Sprog:Inglês
Udgivet: Dove Medical Press 2025-09-01
Serier:Drug Design, Development and Therapy
Fag:
Breast cancer
Human epidermal growth factor receptor 2
Trastuzumab-resistant
Pyrotinib
Eribulin
Online adgang:https://www.dovepress.com/eribulin-plus-pyrotinib-in-trastuzumab-resistant-her2-positive-advance-peer-reviewed-fulltext-article-DDDT
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker